Document is current
Any future updates will be listed below
-
Authors
Aiello, Edoardo Nicolò
Solca, Federica
Torre, Silvia
Gentile, Francesco
Scheveger, Francesco
Olivero, Marco
Colombo, Eleonora
Maranzano, Alessio
Manzoni, Martina
Morelli, Claudia
Doretti, Alberto
Verde, Federico
Silani, Vincenzo
Ticozzi, Nicola
Poletti, Barbara https://orcid.org/0000-0003-4398-2051
-
Funding
Funding for this research was provided by:
Ministero della Salute
- License Information
-
More Information
Article History
Received: 26 July 2023
Accepted: 10 September 2023
First Online: 29 September 2023
Declarations
:
: This study was approved by the Ethics Committees of IRCCS Istituto Auxologico Italiano (I.D.: 2013_06_25).
: Participants provided informed consent.
: VS received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb S.r.l., Novartis Pharma AG and Zambon and receives or has received research supports from the Italian Ministry of Health, AriSLA and E-Rare Joint Transnational Call. He is in the Editorial Board of <i>Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration</i>, <i>European Neurology</i>, <i>American Journal of Neurodegenerative Diseases</i>, <i>Frontiers in Neurology</i> and <i>Exploration of Neuroprotective Therapy</i>. BP received compensation for consulting services and/or speaking activities from Liquidweb S.r.l. She is Associate Editor for <i>Frontiers in Neuroscience</i>. NT received compensation for consulting services from Amylyx Pharmaceuticals and Zambon Biotech SA. He is Associate Editor for <i>Frontiers in Aging Neuroscience</i>.
